ASHLEY HILLARD: Open Payments
NPI 1962649285 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: Kerendia, Vafseo, VOYXACT, FARXIGA, JYNARQUE, FUROSCIX.
Industry payments across LA — which companies pay providers there.
